Axon Enterprise, Inc.

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Axon Enterprise, Inc. reported 1 stock position worth $27.2 million. Its top holding was Cellebrite Di (CLBT) at 100.0% of the portfolio. Compared with Q3 2025, it reduced 1. The biggest sale was Cellebrite Di (CLBT, shares −59%).

Most Recent 13F
Q2 2026
Location
Scottsdale, AZ
CIK
0001069183
Portfolio Value
$27.2M (Q4 2025)
SEC Filing
0001628280-26-008570 ↗ filed Feb 17, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q4 2024: $198.3M Q4 2024 Q1 2025: $174.9M Q1 2025 Q2 2025: $144.0M Q2 2025 Q3 2025: $68.2M Q3 2025 Q4 2025: $27.2M $27.2M Q4 2025 Q1 2026: $18.1M Q1 2026 Q2 2026: $19.1M Q2 2026

Holdings 1 stocks · $27.2M

CLBT Cellebrite Di Ltd. 100.00% 1,509,341 $27.2M Reduce -59.0%

Portfolio Sells Q3 2025 → Q4 2025

CLBT Cellebrite Di Ltd. Reduce -59.0% 100.00% 0.00

Portfolio Buys Q3 2025 → Q4 2025

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$19.1MCLBT
Q1 2026 1$18.1MCLBT
Q4 2025 1$27.2MCLBT
Q3 2025 1$68.2MCLBT
Q2 2025 1$144.0MCLBT
Q1 2025 1$174.9MCLBT
Q4 2024 1$198.3MCLBT